Digital Health Intervention to Promote Quality of Life in Adults With Chronic Graft Versus Host Disease
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- Percentage of participant enrollment
研究概览
简要总结
The goal of this interventional study is to learn if the Horizons mobile application is feasible for survivors of allogeneic hematopoietic stem cell transplant who have chronic graft-versus-host disease. Participants will be asked to complete surveys and use the Horizons mobile application.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Underwent allogeneic hematopoietic stem cell transplant
- •Have moderate to severe chronic graft-versus-host disease
- •Currently receiving care at the Sylvester Comprehensive Cancer Center Bone Marrow Transplant Program
- •Able to use an Ipad to participate in the Horizons app intervention
- •Able to participate in study procedures in English
排除标准
- •comorbid conditions or cognitive impairment that the treating clinician believes prohibits informed consent or participation in the intervention
- •Vulnerable patients, defined here as prisoners and pregnant women
研究组 & 干预措施
Horizons Digital Health Application Group
Participants will receive the Horizons mobile application for up to 6 weeks.
干预措施: Horizons App Intervention (Behavioral)
结局指标
主要结局
Percentage of participant enrollment
时间窗: Up to 8-week follow-up
Participant enrollment will be demonstrated if ≥60% eligible participants enroll.
Percentage of participant retention
时间窗: Up to 8-week follow-up
Participant retention will be demonstrated if ≥80% participants are retained in the study.
次要结局
未报告次要终点
研究者
Lara Traeger
Associate Professor
University of Miami